De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features.
- DOI
- 10.1016/j.leukres.2022.106857
- Published
- 2022 Jun
- Container
- Leukemia research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.leukres.2022.106857,
title = {De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features.},
author = {Epstein-Peterson ZD and Spitzer B and Derkach A and Arango JE and McCarter JGW and Medina-Martínez JS and McGovern E and Farnoud NR and Levine RL and Tallman MS},
year = {2022},
journal = {Leukemia research},
doi = {10.1016/j.leukres.2022.106857},
url = {https://doi.org/10.1016/j.leukres.2022.106857}
}RIS
TY - JOUR TI - De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features. AU - Epstein-Peterson ZD AU - Spitzer B AU - Derkach A AU - Arango JE AU - McCarter JGW AU - Medina-Martínez JS AU - McGovern E AU - Farnoud NR AU - Levine RL AU - Tallman MS PY - 2022 JO - Leukemia research DO - 10.1016/j.leukres.2022.106857 UR - https://doi.org/10.1016/j.leukres.2022.106857 ER -
APA
ZD, E., B, S., A, D., JE, A., JGW, M., JS, M., E, M., NR, F., RL, L., & MS, T. (2022). De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features.. Leukemia research. https://doi.org/10.1016/j.leukres.2022.106857
Source records
- pubmed · retrieved 2026-09-26T22:11:23.138Z
- europe-pmc · retrieved 2026-09-26T22:11:23.155Z